Physician profile
Beth A Moore
NPI 1720139488
$4,046.57
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $572 · 2021: $610 · 2022: $1,531 · 2023: $599 · 2024: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,688.00 | 2019-2023 | Da Vinci Surgical System |
| Ferring Pharmaceuticals INC. | $747.80 | 2019-2024 | Clenpiq, Rebyota |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $386.21 | 2020-2023 | Relistor |
| Thd America, INC. | $170.45 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $143.38 | 2019-2023 | Gattex |
| Prescient Surgical | $138.61 | 2019 | |
| Medtronic, INC. | $112.89 | 2024 | Interstim |
| Braintree Laboratories, INC. | $86.07 | 2019-2021 | |
| Exact Sciences Corporation | $74.37 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $72.49 | 2023-2024 | Andexxa |
| Endo Pharmaceuticals INC. | $62.54 | 2020-2022 | |
| Novo Nordisk INC | $55.42 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $47.40 | 2019 | |
| Palette Life Sciences, INC. | $46.83 | 2019-2021 | |
| Acell, INC. | $38.75 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vioptix INC | $28.77 | 2021 | |
| Teleflex LLC | $25.75 | 2024 | Solesta |
| Covidien Lp | $23.07 | 2019 | |
| Puma Biotechnology, INC. | $21.20 | 2022 | |
| Zyla Life Sciences, INC. | $18.44 | 2020 | |
| Daiichi Sankyo INC. | $17.99 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.27 | 2021 | |
| Shionogi INC | $13.09 | 2019 | |
| Ethicon US, LLC | $11.78 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.